Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier
- PMID: 80457
Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier
Abstract
Following in vitro stimulation of murine sarcoma virus Moloney isolate (M-MuSV)-immune spleen cells with syngeneic antigenically related Moloney leukemia cells, highly efficient cytotoxic T-lymphocytes (CTL's) were generated. The cytotoxic effect was directed only against H-2-compatible target cells bearing M-MuSV tumor-associated antigens (TAA). However, in a cold target competition assay a weak but detectable capacity to block CTL activity was also obtained when allogeneic Moloney leukemia cells were added. Moreover, when M-MuSV-immune spleen cells from mice inoculated with virus 14 days previously were stimulated by allogeneic Moloney leukemia cells, a strong cytotoxic effect toward syngeneic and allogeneic tumor cells bearing M-MuSV TAA was elicited.
Similar articles
-
Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.Eur J Immunol. 1976 Nov;6(11):823-9. doi: 10.1002/eji.1830061114. Eur J Immunol. 1976. PMID: 187429
-
T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.J Immunol. 1981 Jan;126(1):187-93. J Immunol. 1981. PMID: 6969741
-
In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.Cancer Res. 1979 Dec;39(12):4887-93. Cancer Res. 1979. PMID: 387218
-
Stimulation of tumor cell growth in vitro: a critical evaluation of immunologic specificity.J Natl Cancer Inst. 1977 Sep;59(3):769-74. doi: 10.1093/jnci/59.3.769. J Natl Cancer Inst. 1977. PMID: 70536 Review. No abstract available.
-
Characterization of gP85gag as an antigen recognized by Moloney leukemia virus-specific cytolytic T cell clones that function in vivo.J Exp Med. 1985 Jul 1;162(1):128-44. doi: 10.1084/jem.162.1.128. J Exp Med. 1985. PMID: 3891902 Free PMC article. Review.
Cited by
-
Interaction of lymphokine-activated killer cells with susceptible targets does not induce second messenger generation and cytolytic granule exocytosis.J Exp Med. 1989 Sep 1;170(3):665-77. doi: 10.1084/jem.170.3.665. J Exp Med. 1989. PMID: 2769181 Free PMC article.
-
Temporary inhibition of Moloney-murine sarcoma virus (M-MSV) induced-tumours by adoptive transfer of ricin-treated T-lymphocytes.Br J Cancer. 1987 Apr;55(4):413-9. doi: 10.1038/bjc.1987.81. Br J Cancer. 1987. PMID: 2437947 Free PMC article.
-
Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases.Cancer Immunol Immunother. 1992;35(1):27-32. doi: 10.1007/BF01741051. Cancer Immunol Immunother. 1992. PMID: 1611620 Free PMC article.
-
In vitro malignant progression of cells derived from Abelson murine leukaemia virus-induced thymic lymphomas.Br J Cancer. 1988 Aug;58(2):152-7. doi: 10.1038/bjc.1988.183. Br J Cancer. 1988. PMID: 3262364 Free PMC article.